Dr. Steven Rosenberg is ushering in a new age of genetics. In 1991, he helped identify scores of genes and devoloped ways to deliver correct copies of faulty genes to disease victims. At the National Institutes of Health, Rosenberg is now slipping new genes into skin cancer patients, hoping to vaccinate them against spreading tumors.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.